← Back to patent-cliff list

Pulrodemstat

Tier C — Watch / trade

Pulrodemstat

Celgene Corporation
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:LSD1

Indications (approved):Neoplasm, Prostate cancer, Small cell lung cancer, Non-Hodgkin lymphoma, Myeloid leukaemia

Regional status

US
Phase II
2020-07-14
EU
Phase II
2020-07-14
China
-
Japan
Discontinued
2016-08-31

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 6 · Total yield 4.05 g (CC-90011)
CC-90011-0011780-40-1CC-90011-00224688-43-5CC-90011-0031821308-45-5CC-90011-00473874-95-0CC-90011-0051821308-46-6CC-90011-006843663-18-3CC-90011-0071821308-49-9CC-90011-008149507-26-6CC-90011-0091821308-50-2API · Pulrodemstat
CodeCAS No.Intermediate
CC-90011-0011780-40-1perchloropyrimidine
CC-90011-00224688-43-52,5,6-trichloropyrimidin-4-ol
CC-90011-0031821308-45-52,5,6-trichloro-3-methylpyrimidin-4(3H)-one
CC-90011-00473874-95-0tert-butyl piperidin-4-ylcarbamate
CC-90011-0051821308-46-6tert-butyl (1-(4,5-dichloro-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)piperidin-4-yl)carbamate
CC-90011-006843663-18-3(4-cyano-3-fluorophenyl)boronic acid
CC-90011-0071821308-49-9tert-butyl (1-(5-chloro-4-(4-cyano-3-fluorophenyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)piperidin-4-yl)carbamate
CC-90011-008149507-26-6(3-fluoro-4-methoxyphenyl)boronic acid
CC-90011-0091821308-50-2tert-butyl (1-(4-(4-cyano-3-fluorophenyl)-5-(3-fluoro-4-methoxyphenyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)piperidin-4-yl)carbamate

Frequently asked questions

What are the approved indications of Pulrodemstat?

Approved indications include: Neoplasm, Prostate cancer, Small cell lung cancer, Non-Hodgkin lymphoma, Myeloid leukaemia.

When does the Pulrodemstat patent expire?

No public expiry year is available for Pulrodemstat yet; this page updates once verified.

How many synthesis routes are recorded for Pulrodemstat?

1 synthesis routes are recorded; the shortest is 6 steps with 4.05 g (CC-90011) total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Pulrodemstat intermediates?

All intermediates in Pulrodemstat routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Pulrodemstat intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-22